FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML)J.E. Lancet, T.L. Lin,D. Hogge,S.R. Solomon, G.J. Schiller,M.J. Wieduwilt,R. Martin,S. Faderl, Y. Chang,J.E. CortesHematology, Transfusion and Cell Therapy（2020）引用 3|浏览36暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
